Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-14

Clinical Trial Update: Evaluation of ADM(SC Derm® Recon) in Breast Reconstruction

View source ↗

Summary

A clinical trial evaluating ADM(SC Derm Recon) for breast reconstruction in breast cancer patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADM(SC Derm Recon)

Snippet

Sponsor: DOF Inc. | Conditions: Breast Cancer Female | Status: RECRUITING